|
|
The China Alzheimer Report 2026
ZHI Nan, XU Gang, REN Rujing, LIN Shaohui, HUANG Zishuo, HU Yisong, GENG Jieli, SONG Yaying, CAO Wenwei, WANG Jintao, XIAO Jinwen, LI Haixia, XIE Xinyi, LI Jianping, JI Chenhui, ZHANG Bei, ZHOU Ying, ZHOU Yan, LI Yansheng, XU Qun, YANG Junjie, WANG Yiran, GAO Mengyi, LIU Langyan, PAN Xu, ZHU Yikang, HUANG Yucheng, CHEN Shengdi, CHEN Xiaochun, WANG Ying, LI Chunbo, WANG Gang
Journal of Diagnostics Concepts & Practice
2026, 25 (05):
523-564.
DOI: 10.16150/j.1671-2870.2026.05.001
With the continuing deepening of population aging in China, neurodegenerative diseases represented by Alzheimer's disease (AD) have become a major public health challenge that seriously affects the health and quality of life of older adults. In 2023, the number of people living with AD and other dementias in China reached 20.299 million, accoun-ting for approximately 33.75% of the global total; there were 3.477 million new cases and 0.586 million deaths, and the di-sease burden ranked first in the world. To further delineate the epidemiological trends, the current status of diagnosis and treatment, and the allocation of public health resources for AD in China, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, together with experts from Shanghai Jiao Tong University School of Public Health, Fudan University School of Public Health, Shanghai Mental Health Center and other authoritative institutions, compiled The China Alzheimer Report 2026 on the basis of the 2022, 2023, 2024 and 2025 reports. This report updates the epidemiological data to 2023, systematically reviews the latest therapeutic advances, including disease-modifying therapies, neuromodulation, deep cervical lymphatic-venous anastomosis, traditional Chinese medicine and cognitive training interventions, and comprehensively updates the latest policy documents such as the National Action Plan for Responding to Dementia in Old Age (2024-2030) as well as the current status of public health resource allocation. This report aims to provide a scientific basis for the prevention, diagnosis and treatment of AD, to provide data support for the government in formulating health policies, and to promote joint efforts of all sectors of society to advance the cause of elderly health in China, so as to conti-nuously empower the realization of "healthy aging".
Table and Figures |
Reference |
Related Articles |
Metrics |
Comments(0)
|
|